MIRADOR
Live / Applied — Third extension granted (statement of use) (as of 17 Aug 2026)
What this means for you
Not registered yet, but its 09 Nov 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98262764
- Mark type
- Stylized text
- Filed
- 09 Nov 2023
- Published for opposition
- 01 Oct 2024
- Attorney of record
- Brent D. Sokol
Goods and services
- Class 001 — Chemicals: Active pharmaceutical ingredients, namely, antibodies, proteins and small molecules for use in the manufacture of pharmaceuticals, biopharmaceuticals, vaccines, and finished drug products for the diagnosis, prevention, or treatment of inflammation and immunology disorders or diseases, autoimmune diseases, cancer, and other diseases of the immune systems, digestive systems, skin, joint, lung, liver, kidney, bile duct, nervous systems, or gastrointestinal systems; Antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines
Owner
- Mirador Therapeutics, Inc., San Diego, CA, US
- Mirador Therapeutics, Inc., San Diego, CA, US
Prosecution history
- 17 Aug 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Aug 2026 — CORRECTED NOA E-MAILED
- 17 Aug 2026 — SOU EXTENSION 3 GRANTED
- 25 May 2026 — SOU EXTENSION 3 FILED
- 17 Aug 2026 — DIVISIONAL PROCESSING COMPLETE
- 26 May 2026 — DIVISIONAL REQUEST RECEIVED
- 26 May 2026 — TEAS REQUEST TO DIVIDE RECEIVED
- 14 Aug 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 26 May 2026 — SOU TEAS EXTENSION RECEIVED
- 26 May 2026 — TEAS STATEMENT OF USE RECEIVED
- 02 Apr 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 02 Apr 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 02 Apr 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 26 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Nov 2025 — SOU EXTENSION 2 GRANTED